{
  "subset": "contraindication",
  "disease": "Bardet-Biedl Syndrome",
  "relation": "contraindication",
  "gold_drugs": [
    "administered subcutaneously [sc] + once daily. + setmelanotide",
    "metformin",
    "setmelanotide"
  ],
  "seeds_initial": [
    "Ibuprofen",
    "Digoxin",
    "Acetazolamide",
    "Naproxen",
    "Gentamicin",
    "Thiazide Diuretics",
    "Propranolol",
    "Methotrexate",
    "Sodium Chloride",
    "Fluoroquinolones",
    "Lithium",
    "Amiodarone"
  ],
  "seed_history": [
    [
      "Ibuprofen",
      "Digoxin",
      "Acetazolamide",
      "Naproxen",
      "Gentamicin",
      "Thiazide Diuretics",
      "Propranolol",
      "Methotrexate",
      "Sodium Chloride",
      "Fluoroquinolones",
      "Lithium",
      "Amiodarone"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_ibuprofen",
          "name": "Ibuprofen"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Ibuprofen 被确认与 Bardet-Biedl Syndrome 之间存在禁忌关系",
          "潜在的副作用风险已被识别"
        ],
        "caveats": [
          "可能风险需进一步分析以确认其临床意义"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_digoxin",
          "name": "Digoxin"
        },
        "score": 0.68,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Digoxin 被确认与 Bardet-Biedl Syndrome 之间存在禁忌关系",
          "潜在的副作用风险已被识别"
        ],
        "caveats": [
          "可能风险需进一步分析以确认其临床意义"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_acetazolamide",
          "name": "Acetazolamide"
        },
        "score": 0.62,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Acetazolamide 被确认与 Bardet-Biedl Syndrome 之间存在禁忌关系",
          "可能影响电解质平衡的风险已被识别"
        ],
        "caveats": [
          "可能风险需进一步分析以确认其临床意义"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Disease (contraindication) → Adverse Phenotype",
          "reason": "所有推荐药物存在已知的禁忌关系，且与不良表型相关联"
        }
      ],
      "remaining_gaps": [
        "需更详细的临床样本数据支持每种药物的安全性评估"
      ]
    },
    "heuristics": [],
    "prompt_patches": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Bardet-Biedl Syndrome'. Return only names.\n\n# Prior guidance for Explorer:\n- 扩展对现有药物的机制解释，考虑更广范围的适用性与效果\n\n# Heuristics:\n- When Bardet-Biedl Syndrome患者: then 应优先考虑避免可能加重肾功能的药物"
}